Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Aims to deliver a comprehensive solution aimed at enhancing the quality, safety and regulatory compliance of adverse event monitoring in drug development
January 29, 2019
By: Kristin Brooks
Managing Editor, Contract Pharma
The WIRB-Copernicus Group’s (WCG) Clinical Services Division has partnered with Prudentia Group, a provider of drug safety and pharmacovigilance consulting services, to deliver a comprehensive solution aimed at enhancing the quality, safety and regulatory compliance of adverse event monitoring in drug development. Through its subsidiary, Vigilare International, WCG provides drug safety and pharmacovigilance services including consulting and quality assurance, adverse event processing, medical information and contact center, risk management and aggregate reporting, operational support and staffing. Prudentia’s team of drug safety and pharmacovigilance experts will work with WCG’s product vigilance service, giving clients access to scientific, regulatory and operational guidance in the management of their safety programs. Prudentia will complement WCG’s offering with enhanced organizational, operational, and technical strategies to support clients by leading them through the implementation of those strategies, which may include helping them to move to new technologies, more cost-effective outsourcing models, or better, more compliant risk management processes. “In clinical trials, we are constantly weighing risks and benefits, always aiming to achieve a balance between the two,” said Donald A. Deieso, Ph.D., executive chairman and chief executive officer of WCG. “Monitoring research in real time, our safety and pharmacovigilance professionals keep patients safe by alerting us when the balance might be changing. Through our partnership with Prudentia Group, we are adding critical elements that will make our solution more powerful for clients, helping them make better, faster decisions with a greater degree of confidence. Because when your job is protecting patients, you need access to the right information at the right time to be able to make a difference.” “We are proud to partner with WCG to enhance the quality and safety of clinical development,” said Vladimir Laguerre, Founding Partner, Prudentia Group. “Our organizations are committed to helping clients streamline safety operations while increasing quality and compliance. Together, we will give clients faster access to high-quality, regulatory compliant, inspection-ready data.”
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !